El Khiati Rhizlane, Tighilet Brahim, Besnard Stephane, Chabbert Christian
Team Pathophysiology and Therapy of Vestibular Disorders, Laboratory of Cognitive Neurosciences, UMR7291, Aix Marseille University-CNRS, CEDEX 07, 13007 Marseille, France.
Research Group on Vestibular Pathophysiology, Unit GDR2074 CNRS, Aix Marseille University-CNRS, CEDEX 07, 13284 Marseille, France.
Brain Sci. 2022 May 2;12(5):592. doi: 10.3390/brainsci12050592.
The vestibular system exerts control over various functions through neural pathways that are not yet fully mapped. Functional dysregulations or tissue lesions at different levels of the peripheral and the central vestibular networks can alter these different functions, causing a wide variety of symptoms, ranging from posturo-locomotor alterations to psychiatric syndromes such as PPPD, including the deregulation of the main biological functions. These different symptoms differ by their expression kinetics (they each appear and regress with their own kinetics) by the targets affected (muscles, organs, and brain areas) and by the sensitivity specific to each individual. Vestibular pathologies thus cover a mosaic of distinct effects, and they involve various effectors-which constitute the many markers of their different types and stages. It is therefore crucial, to predict the onset of a vertigo syndrome, to follow its temporal course, or to monitor the impact of therapeutic approaches, and to have specific and reliable biomarkers. Hormonal variations are among the possible sources of biomarkers for neurotology. We know that specific hormonal profiles can promote the appearance of vestibular disorders. We also know that the expression of vertigo syndrome is accompanied by measurable hormonal variations. The link between endocrine deregulation and vestibular alterations therefore no longer needs to be proven. However, there are still few data on their precise correlations with the vertigo syndrome. This study was undertaken with the aim to deliver an extensive review of the hormonal alterations linked to vestibular disorders. A review of the literature covering the last two decades was carried out using the MEDLINE and COCHRANE databases in order to identify studies associating the terms vestibular system or vestibular pathologies and hormones. Bibliographic data provides several outcomes in terms of therapeutic innovation in the diagnosis and therapeutic follow-up of vestibular pathologies.
前庭系统通过尚未完全明确的神经通路对各种功能进行控制。外周和中枢前庭网络不同水平的功能失调或组织损伤会改变这些不同功能,引发各种各样的症状,从姿势 - 运动改变到诸如持续性姿势 - 知觉性头晕(PPPD)等精神综合征,包括主要生物功能的失调。这些不同症状在表达动力学(它们各自以自己的动力学出现和消退)、受影响的靶点(肌肉、器官和脑区)以及个体特异性敏感性方面存在差异。因此,前庭疾病涵盖了一系列不同的影响,涉及各种效应器——这些效应器构成了其不同类型和阶段的众多标志。所以,对于预测眩晕综合征的发作、跟踪其时间进程或监测治疗方法的效果而言,拥有特异性和可靠的生物标志物至关重要。激素变化是神经耳科学可能的生物标志物来源之一。我们知道特定的激素谱可促使前庭疾病的出现。我们也知道眩晕综合征的发作伴随着可测量的激素变化。因此,内分泌失调与前庭改变之间的联系无需再被证明。然而,关于它们与眩晕综合征的确切相关性的数据仍然很少。本研究旨在对与前庭疾病相关的激素变化进行广泛综述。使用MEDLINE和COCHRANE数据库对过去二十年的文献进行了综述,以识别将前庭系统或前庭疾病与激素相关联的研究。书目数据在前庭疾病诊断和治疗随访的治疗创新方面提供了若干成果。